Gossamer Bio, Inc.
GOSS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728117
No open-market purchases or sales by Gossamer Bio, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding Gossamer Bio, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 109 | 94 | −15 |
| Shares | 197.8M | 182.9M | −14.9M (−7.6%) |
| Value | $233.5M | $164.7M | −$68.8M (−29.5%) |
New holders (11)
Institutions that held Gossamer Bio, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 5,487,516 | $4.94M | 0.03% |
| Exome Asset Management LLC | 1,127,699 | $1.02M | 0.90% |
| Algert Global LLC | 83,543 | $75.3K | 0.00% |
| RSM US Wealth Management LLC | 48,111 | $45.6K | 0.00% |
| Nomura Holdings Inc | 40,000 | $36.0K | 0.00% |
| Trellis Wealth Advisors LLC | 15,000 | $13.5K | 0.01% |
| Moors & Cabot, Inc. | 10,000 | $9.01K | 0.00% |
| Traynor Capital Management, Inc. | 10,000 | $9.01K | 0.00% |
| Cape Investment Advisory, Inc. | 7,000 | $6.31K | 0.00% |
| McMahon Financial Advisors, LLC | 1,872 | $1.69K | 0.00% |
| Global Retirement Partners, LLC | 300 | $270 | 0.00% |
Sold out (26)
Institutions that held Gossamer Bio, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.